Leukemia Therapeutics Market by Disease type, Geography, Analysis and Forecast 2020
ReportsWeb.com published “Leukemia Therapeutics Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, April 27, 2017 ) Cancer that starts from hematopoietic stem cells of the bone marrow is referred to as leukemia. Leukemia can be chronic or acute depending on the maturity of the cells. Also, based on the bone marrow cells from which cancer starts, leukemia can be categorized as lymphocytic or myeloid.
Publisher's analysts forecast the leukemia therapeutics market to grow at a CAGR of 8.44% during the period 2016-2020.
For more information about this report: http://www.reportsweb.com/global-leukemia-therapeutics-market-2016-2020
Covered in this report
The report covers the present scenario and the growth prospects of the leukemia therapeutics market for 2016-2020. To calculate the market size, the report considers the the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of different types of leukemias.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Publisher's report, Leukemia Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- F. Hoffmann-La Roche
- Novartis
- Bristol-Myers Squibb
- AbbVie
- Teva Pharmaceuticals
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001409083/sample
Other prominent vendors
- Altor BioScience
- Amgen
- ARIAD Pharmaceuticals
- Arno Therapeutics
- Astex Pharmaceuticals
- AstraZeneca
- Baxter Healthcare
- Bayer HealthCare
- Bellicum Pharmaceuticals
- Biogen
- Boehringer Ingelheim
- BioLineRx
- Boston Biomedical
- Celator Pharmaceuticals
- Celgene
- CTI BioPharma
- Chroma Therapeutics
- Chugai Pharmaceutical
- Cyclacel Pharmaceuticals
- Daiichi Sankyo
- Eisai
- Emergent BioSolutions
- Erytech Pharma
- Fate Therapeutics
- Genzyme
- Gilead Sciences
- GlaxoSmithKline
- iDD biotech
- Immune Pharmaceuticals
- Immunomedics
- Infinity Pharmaceuticals
- Innate Pharma
- Jazz Pharmaceuticals
- Juno Therapeutics
- Karyopharm Therapeutics
- Ligand Pharmaceuticals
- MEDA Pharmaceuticals
- MedImmune
- Merck
- Midas Pharma
- Molecular Templates
- MorphoSys
- Nippon Shinyaku
- Novo Nordisk
- Onconova Therapeutics
- Ono Pharmaceuticals
- Orphan Europe
- Otsuka
- Pfizer
- Portola Pharmaceuticals
- Regeneron Pharmaceuticals
- Sanofi
- Sigma-Tau Pharmaceuticals
- Stemline Therapeutics
- Sunesis Pharmaceuticals
- TG Therapeutics
- TheraMAB
- Tolero Pharmaceuticals
- XEME Biopharma
- Xencor
- ZIOPHARM Oncology
Market driver
- Technological advances in the monitoring of leukemia
- For a full, detailed list, view our report
Market challenge
- Limitations associated with current therapeutic options
- For a full, detailed list, view our report
Market trend
- Rise in the development of combination therapies
- For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001409083/buying
Table of Contents:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Pipeline portfolio
PART 06: Market landscape
PART 07: Market segmentation by disease type
PART 08: Global CLL therapeutics market
PART 09: Global ALL therapeutics market
PART 10: Global AML therapeutics market
PART 11: Global CML therapeutics market
PART 12: Geographical segmentation
PART 13: Market drivers
PART 14: Impact of drivers
PART 15: Market challenges
PART 16: Impact of drivers and challenges
PART 17: Market trends
PART 18: Vendor landscape
PART 19: Key vendor analysis
PART 20: Appendix
Purchase this Premium Research Report at: http://www.reportsweb.com/buy&RW0001409083/buy/2500 .
Publisher's analysts forecast the leukemia therapeutics market to grow at a CAGR of 8.44% during the period 2016-2020.
For more information about this report: http://www.reportsweb.com/global-leukemia-therapeutics-market-2016-2020
Covered in this report
The report covers the present scenario and the growth prospects of the leukemia therapeutics market for 2016-2020. To calculate the market size, the report considers the the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of different types of leukemias.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Publisher's report, Leukemia Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- F. Hoffmann-La Roche
- Novartis
- Bristol-Myers Squibb
- AbbVie
- Teva Pharmaceuticals
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001409083/sample
Other prominent vendors
- Altor BioScience
- Amgen
- ARIAD Pharmaceuticals
- Arno Therapeutics
- Astex Pharmaceuticals
- AstraZeneca
- Baxter Healthcare
- Bayer HealthCare
- Bellicum Pharmaceuticals
- Biogen
- Boehringer Ingelheim
- BioLineRx
- Boston Biomedical
- Celator Pharmaceuticals
- Celgene
- CTI BioPharma
- Chroma Therapeutics
- Chugai Pharmaceutical
- Cyclacel Pharmaceuticals
- Daiichi Sankyo
- Eisai
- Emergent BioSolutions
- Erytech Pharma
- Fate Therapeutics
- Genzyme
- Gilead Sciences
- GlaxoSmithKline
- iDD biotech
- Immune Pharmaceuticals
- Immunomedics
- Infinity Pharmaceuticals
- Innate Pharma
- Jazz Pharmaceuticals
- Juno Therapeutics
- Karyopharm Therapeutics
- Ligand Pharmaceuticals
- MEDA Pharmaceuticals
- MedImmune
- Merck
- Midas Pharma
- Molecular Templates
- MorphoSys
- Nippon Shinyaku
- Novo Nordisk
- Onconova Therapeutics
- Ono Pharmaceuticals
- Orphan Europe
- Otsuka
- Pfizer
- Portola Pharmaceuticals
- Regeneron Pharmaceuticals
- Sanofi
- Sigma-Tau Pharmaceuticals
- Stemline Therapeutics
- Sunesis Pharmaceuticals
- TG Therapeutics
- TheraMAB
- Tolero Pharmaceuticals
- XEME Biopharma
- Xencor
- ZIOPHARM Oncology
Market driver
- Technological advances in the monitoring of leukemia
- For a full, detailed list, view our report
Market challenge
- Limitations associated with current therapeutic options
- For a full, detailed list, view our report
Market trend
- Rise in the development of combination therapies
- For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001409083/buying
Table of Contents:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Pipeline portfolio
PART 06: Market landscape
PART 07: Market segmentation by disease type
PART 08: Global CLL therapeutics market
PART 09: Global ALL therapeutics market
PART 10: Global AML therapeutics market
PART 11: Global CML therapeutics market
PART 12: Geographical segmentation
PART 13: Market drivers
PART 14: Impact of drivers
PART 15: Market challenges
PART 16: Impact of drivers and challenges
PART 17: Market trends
PART 18: Vendor landscape
PART 19: Key vendor analysis
PART 20: Appendix
Purchase this Premium Research Report at: http://www.reportsweb.com/buy&RW0001409083/buy/2500 .
Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results